(BTLS) Biotalys - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974386188
BTLS: Biofungicides, Bioinsecticides
Biotalys NV, a pioneering agricultural technology company, specializes in the discovery and development of innovative biological solutions for sustainable crop protection. Headquartered in Gent, Belgium, the company operates globally, focusing on reducing the environmental impact of agriculture through effective and eco-friendly biofungicides and bioinsecticides. Biotalys product pipeline includes EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6, which target high-value crops such as fruits and vegetables, addressing diseases like botrytis, powdery mildew, and anthracnose. Additionally, BIOFUN-7 is designed to combat leafspot disease in cowpeas and other legumes, while BIOFUN-4 targets oomycetes in fruits and vegetables. The company, formerly known as Agrosavfe NV, was incorporated in 2013 and is listed on Euronext Brussels under the ticker symbol BTLS. Biotalys is committed to advancing sustainable agriculture by providing farmers with reliable, natural alternatives to conventional chemical pesticides.
Biotalys NV is strategically positioned in the Fertilizers & Agricultural Chemicals sector, addressing the growing demand for biological crop protection solutions. The companys research and development efforts are centered on improving crop yields and reducing pesticide resistance, aligning with global trends toward sustainable farming practices. Its product portfolio is designed to meet the needs of both conventional and organic farming systems, ensuring broad market applicability. With a strong focus on innovation, Biotalys collaborates with agricultural experts, research institutions, and industry partners to enhance its biological solutions and expand its market reach.
3-Month Forecast Based on the providedAdditional Sources for BTLS Stock
BTLS Stock Overview
| Market Cap in USD | 137m |
| Sector | Basic Materials |
| Industry | Agricultural Inputs |
| GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception |
BTLS Stock Ratings
| Growth Rating | -45.5 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | 7.13 |
| Analysts | - |
| Fair Price Momentum | 2.55 EUR |
| Fair Price DCF | - |
BTLS Dividends
No Dividends PaidBTLS Growth Ratios
| Growth Correlation 3m | -24.8% |
| Growth Correlation 12m | 63% |
| Growth Correlation 5y | -89.5% |
| CAGR 5y | -18.80% |
| CAGR/Max DD 5y | -0.24 |
| Sharpe Ratio 12m | -0.10 |
| Alpha | -1.80 |
| Beta | 0.632 |
| Volatility | 45.98% |
| Current Volume | 3.3k |
| Average Volume 20d | 9.3k |
As of April 19, 2025, the stock is trading at EUR 3.12 with a total of 3,286 shares traded.
Over the past week, the price has changed by -3.11%, over one month by -12.61%, over three months by -7.42% and over the past year by -0.95%.
Probably not. Based on ValueRay Analyses, Biotalys (BR:BTLS) is currently (April 2025) not a good stock to buy. It has a ValueRay Growth Rating of -45.52 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BTLS as of April 2025 is 2.55. This means that BTLS is currently overvalued and has a potential downside of -18.27%.
Biotalys has no consensus analysts rating.
According to ValueRays Forecast Model, BTLS Biotalys will be worth about 2.8 in April 2026. The stock is currently trading at 3.12. This means that the stock has a potential downside of -10.58%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 5.2 | 66.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.8 | -10.6% |